423 results match your criteria: "the Park - Centre for Mental Health[Affiliation]"
Psychol Med
January 2024
Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
Nat Commun
September 2023
National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark.
Proportional hazards models have been proposed to analyse time-to-event phenotypes in genome-wide association studies (GWAS). However, little is known about the ability of proportional hazards models to identify genetic associations under different generative models and when ascertainment is present. Here we propose the age-dependent liability threshold (ADuLT) model as an alternative to a Cox regression based GWAS, here represented by SPACox.
View Article and Find Full Text PDFAust N Z J Psychiatry
November 2023
Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, QLD, Australia.
Nat Commun
August 2023
The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, 8210, Aarhus V, Denmark.
Int J Ment Health Syst
July 2023
Queensland Centre for Mental Health Research The Park - Centre for Mental Health, Locked Bag 500, Sumner Park, BC, QLD, 4074, Australia.
Background: The aim of this study was to demonstrate the application of a needs-based mental health service planning model in Tasmania, Australia to identify indicative directions for future service development that ensure the equitable provision of mental health services across the State.
Methods: The activity and capacity of Tasmania's 2018-19 mental health services were compared to estimates of required care by: (1) generating estimates of required care using the National Mental Health Service Planning Framework (NMHSPF); (2) collating administrative mental health services data; (3) aligning administrative data to the NMHSPF; and (4) comparing aligned administrative data and NMHSPF estimates to identify priority areas for service development. Findings were contextualised using information about service location, population demographics, and upcoming service development.
Nat Med
July 2023
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
J Affect Disord
October 2023
QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; School of Public Health, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia; Queensland Centre for Mental Health Research (QCMHR), The Park Centre for Mental Health, Wacol, QLD, Australia; Child Health Research Centre, The University of Queensland South Brisbane, Qld Australia; Child and Youth Mental Health Service, Children's Hospital Queensland, South Brisbane, Qld, Australia.
Background/objectives: To investigate the effectiveness, feasibility, and acceptability of sense of purpose (SOP) interventions in preventing or reducing anxiety or depression in youth aged 14-24 years.
Methods: A systematic search was conducted of the academic (PubMed/MEDLINE, PsycINFO, EMBASE) and grey literature. We also consulted two SOP experts and an Australian and Indian youth advisory group with lived experience of anxiety and/or depression.
Acta Psychiatr Scand
August 2023
Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Int J Popul Data Sci
May 2023
National Centre for Register-based Research, Aarhus BSS, Aarhus University, Denmark.
Introduction: Surveys and registers have provided important insights into the mental health of the community. However, both sources have strengths and limitations. While participation in surveys has been shown to be lower among those with mental disorders, misclassification and limited information on confounders are typical issues for registers.
View Article and Find Full Text PDFActa Psychiatr Scand
June 2023
Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
Background: Register-based studies of major depressive disorder (MDD) do not capture all prevalent cases, as untreated cases and diagnoses made by general practitioners are not recorded in the registers. We examined the prevalence and agreement of survey- and register-based measures of depression, and explored sociodemographic and health-related factors that may have influenced this agreement.
Methods: All 32,407 participants in the 2017 Central Denmark Region How are you? survey were linked to hospital and prescription records.
BMC Psychiatry
April 2023
Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.
Background: Posttraumatic stress disorder (PTSD) is associated with significant morbidity, but efficacious pharmacotherapy and psychotherapy are available. Data from the World Mental Health Surveys were used to investigate extent and predictors of treatment coverage for PTSD in high-income countries (HICs) as well as in low- and middle-income countries (LMICs).
Methods: Seventeen surveys were conducted across 15 countries (9 HICs, 6 LMICs) by the World Health Organization (WHO) World Mental Health Surveys.
Psychol Med
March 2023
Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
Background: The most common treatment for major depressive disorder (MDD) is antidepressant medication (ADM). Results are reported on frequency of ADM use, reasons for use, and perceived effectiveness of use in general population surveys across 20 countries.
Methods: Face-to-face interviews with community samples totaling = 49 919 respondents in the World Health Organization (WHO) World Mental Health (WMH) Surveys asked about ADM use anytime in the prior 12 months in conjunction with validated fully structured diagnostic interviews.
Psychiatry Res
April 2023
Centre for Mental Health and Brain Sciences, School of Health Sciences, Swinburne University of Technology, Melbourne, VIC, Australia; Department of Mental Health, St Vincent's Hospital, Melbourne, VIC, Australia.
Young Australians have been differentially affected by lockdowns and social restrictions during the COVID-19 pandemic. This study compared the mental health impacts of the COVID-19 pandemic and associated restrictions for young people in two Australian states, Victoria and Queensland, with Victoria experiencing more days in lockdown and greater infection rates. An online survey was completed between 01/04/2021 and 31/07/2021 by 687 young people, aged 16 to 24 years; 337 from Victoria and 350 from Queensland.
View Article and Find Full Text PDFNat Commun
February 2023
National Centre for Register-Based Research, Aarhus University, 8210, Aarhus V, Denmark.
The vitamin D binding protein (DBP), encoded by the group-specific component (GC) gene, is a component of the vitamin D system. In a genome-wide association study of DBP concentration in 65,589 neonates we identify 26 independent loci, 17 of which are in or close to the GC gene, with fine-mapping identifying 2 missense variants on chromosomes 12 and 17 (within SH2B3 and GSDMA, respectively). When adjusted for GC haplotypes, we find 15 independent loci distributed over 10 chromosomes.
View Article and Find Full Text PDFDrug Alcohol Rev
May 2023
National Centre for Youth Substance Use Research, Faculty of Health and Behavioural Sciences, The University of Queensland, Brisbane, Australia.
Introduction: The shifting landscape in Australia's tobacco and cannabis policies and emerging new products and modes of administration may increase experimentation and the risks of addiction to these drugs.
Methods: We analysed cross-sectional data from the 2019 National Drug Strategy and Household Survey (n = 22,015) of Australians aged 14 and above. Latent class analysis was used to identify distinct groups based on types of tobacco and cannabis products used.
Aust N Z J Psychiatry
February 2023
Queensland Centre for Mental Health Research, The Park - Centre for Mental Health, Archerfield, QLD, Australia.
Objective: The Composite International Diagnostic Interview 3.0 is a standardised diagnostic interview commonly used in population-based mental health surveys, but has not been used in community-residing Indigenous Australians. This paper seeks to determine whether the Composite International Diagnostic Interview 3.
View Article and Find Full Text PDFAddiction
May 2023
National Drug and Alcohol Research Centre (NDARC), University of New South Wales Australia, Sydney, NSW, Australia.
Aims: Likelihood of alcohol dependence (AD) is increased among people who transition to greater levels of alcohol involvement at a younger age. Indicated interventions delivered early may be effective in reducing risk, but could be costly. One way to increase cost-effectiveness would be to develop a prediction model that targeted interventions to the subset of youth with early alcohol use who are at highest risk of subsequent AD.
View Article and Find Full Text PDFAust N Z J Psychiatry
March 2023
Mental Health and Neuroscience Programme. QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Mol Cell Biochem
August 2023
Mater Research Institute, The University of Queensland, Translational Research Institute, 37 Kent St, Woolloongabba, QLD, 4102, Australia.
Sulfate is essential for healthy foetal growth and neurodevelopment. The SLC13A1 sulfate transporter is primarily expressed in the kidney where it mediates sulfate reabsorption and maintains circulating sulfate levels. To meet foetal demands, maternal sulfate levels increase by twofold in pregnancy via upregulated SLC13A1 expression.
View Article and Find Full Text PDFNutrients
October 2022
Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol Q4076, Australia.
Twenty of the last one hundred years of vitamin D research have involved investigations of the brain as a target organ for this hormone. Our group was one of the first to investigate brain outcomes resulting from primarily restricting dietary vitamin D during brain development. With the advent of new molecular and neurochemical techniques in neuroscience, there has been increasing interest in the potential neuroprotective actions of vitamin D in response to a variety of adverse exposures and how this hormone could affect brain development and function.
View Article and Find Full Text PDFBJPsych Open
October 2022
National Centre for Register-based Research, Aarhus University, Denmark; and Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Denmark.
Background: General medical conditions (GMCs) often co-occur with mental and substance use disorders (MSDs).
Aims: To explore the contribution of GMCs to the burden of disease in people with MSDs, and investigate how this varied by age.
Method: A population-based cohort of 6 988 507 persons living in Denmark during 2000-2015 followed for up to 16 years.
Aust N Z J Psychiatry
June 2023
Department of Public Health, Aarhus University, Aarhus, Denmark.
Drug Alcohol Depend
November 2022
Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
Aim: Exposure to traumatic events (TEs) is associated with substance use disorders (SUDs). However, most studies focus on a single TE, and are limited to single countries, rather than across countries with variation in economic, social and cultural characteristics. We used cross-national data to examine associations of diverse TEs with SUD onset, and variation in associations over time.
View Article and Find Full Text PDFJ Neuropsychiatry Clin Neurosci
January 2023
Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, Australia (Cohn, Mohan); University of New South Wales, Sydney (Cohn, Mohan, Lappin, Curtis); South Eastern Sydney Local Health District, Sydney (Cohn, Mohan, Lappin, Curtis); Mindgardens Neuroscience Network, Sydney (Curtis); Child and Youth Research Group, QIMR Berghofer Medical Research Institute, and Early Psychosis Service, Metro North Mental Health Service, Herston, Australia (Scott); Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, Australia (Scott).
Anti--methyl-d-aspartate receptor (NMDAR) encephalitis is an immune-mediated disorder that typically presents with rapid development of neuropsychiatric symptoms. As a potentially reversible cause of psychosis, there have been calls internationally for routine serological screening for anti-NMDAR antibodies in patients presenting with first-episode psychosis (FEP). Increased serological testing has, however, exposed several limitations of universal screening and rekindled debate as to which patients should be tested.
View Article and Find Full Text PDF